These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17063197)

  • 1. Reversible posterior leukoencephalopathy associated with minimal change nephrotic syndrome.
    Li Looi J; Christiansen JP
    N Z Med J; 2006 Oct; 119(1243):U2257. PubMed ID: 17063197
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome.
    Ikeda M; Ito S; Hataya H; Honda M; Anbo K
    Am J Kidney Dis; 2001 Apr; 37(4):E30. PubMed ID: 11273900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posterior leukoencephalopathy syndrome in children and adolescents.
    Alehan F; Erol I; Agildere AM; Ozcay F; Baskin E; Cengiz N; Alioglu B; Haberal M
    J Child Neurol; 2007 Apr; 22(4):406-13. PubMed ID: 17621519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reversible posterior leukoencephalopathy: should the area involved be in the name of the syndrome?].
    García Martín G; Serrano Castro V; García Carrasco E; Romero Acebal M
    Neurologia; 2007 Mar; 22(2):122-5. PubMed ID: 17323240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A reversible posterior leukoencephalopathy syndrome.
    Arnoldus EP; Van Laar T
    N Engl J Med; 1996 Jun; 334(26):1745; author reply 1746. PubMed ID: 8637526
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolated cerebellar involvement in a case of posterior reversible leukoencephalopathy.
    Soysal DD; Caliskan M; Aydin K; Nayir A; Karaböcüoglu M; Citak A; Uzel N
    Clin Radiol; 2006 Nov; 61(11):983-6. PubMed ID: 17018313
    [No Abstract]   [Full Text] [Related]  

  • 7. Nephrotic syndrome: minimal change disease.
    Aziz F; Qureshi AM
    J Ayub Med Coll Abbottabad; 2001; 13(4):35-40. PubMed ID: 11873430
    [No Abstract]   [Full Text] [Related]  

  • 8. [Posterior cerebral encephalopathy].
    Boughammoura-Bouatay A; Chebel S; Fitouri F; Hizem Y; Frih-Ayed M
    Tunis Med; 2005 Feb; 83(2):117-9. PubMed ID: 15969236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed.
    Stott VL; Hurrell MA; Anderson TJ
    Intern Med J; 2005 Feb; 35(2):83-90. PubMed ID: 15705136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postcontrast flair MRI demonstrates blood-brain barrier dysfunction in PRES.
    Weier K; Fluri F; Kos S; Gass A
    Neurology; 2009 Feb; 72(8):760-2. PubMed ID: 19237706
    [No Abstract]   [Full Text] [Related]  

  • 11. Minimal-change nephropathy and chronic hepatitis C infection: coincidental or associated?
    Aoyama M; Sugimoto T; Yokono T; Sakaguchi M; Deji N; Uzu T; Kashiwagi A
    Nephrol Dial Transplant; 2007 May; 22(5):1479-80. PubMed ID: 17210595
    [No Abstract]   [Full Text] [Related]  

  • 12. A reversible posterior leukoencephalopathy syndrome.
    Eaton JM
    N Engl J Med; 1996 Jun; 334(26):1744-5; author reply 1746. PubMed ID: 8637525
    [No Abstract]   [Full Text] [Related]  

  • 13. [Minimal change glomerulonephritis].
    Diadyk AI; Siniachenko OV; Vasilenko IV
    Ter Arkh; 1987; 59(10):123-5. PubMed ID: 3324373
    [No Abstract]   [Full Text] [Related]  

  • 14. Minimal change nephrotic syndrome of childhood: current concepts in management.
    Yap HK; Murugasu B
    J Singapore Paediatr Soc; 1990; 32(1-2):18-22. PubMed ID: 2259191
    [No Abstract]   [Full Text] [Related]  

  • 15. Minimal change nephrotic syndrome associated with systemic lupus erythematosus.
    Horino T; Takao T; Morita T; Ito H; Hashimoto K
    Nephrol Dial Transplant; 2006 Jan; 21(1):230. PubMed ID: 16221690
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukoencephalopathy associated with dialysis disequilibrium syndrome.
    Chang CH; Hsu KT; Lee CH; Lee YC; Chiou TT; Chuang CH; Lee CT; Wang IK; Cheng YF; Lu CH; Kuo CC; Chuang FR
    Ren Fail; 2007; 29(5):631-4. PubMed ID: 17654328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimal change nephrotic syndrome with cecum adenocarcinoma.
    Gandini E; Allaria P; Castiglioni A; d'Amato I; Schiaffino E; Giangrande A
    Clin Nephrol; 1996 Apr; 45(4):268-70. PubMed ID: 8861804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimal change nephrotic syndrome showing complete remission after resection of a neurofibroma in a type I neurofibromatosis patient.
    Hyun JI; Min JW; Lee HM; Kim YK; Choi EJ; Song HC
    Korean J Intern Med; 2017 Jan; 32(1):186-189. PubMed ID: 26951918
    [No Abstract]   [Full Text] [Related]  

  • 19. [Minimal-change nephrotic syndrome associated with an undifferentiated urothelial carcinoma].
    Cases A; Torras A; Lens XM; Revert L
    Med Clin (Barc); 1986 Mar; 86(10):436. PubMed ID: 3713303
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progressive renal diseases: recent advances in diagnosis and treatments. Topics: II. Pathophysiology and treatments; 1. Pathogenesis and management of minimal change nephrotic syndrome].
    Tsuruya K
    Nihon Naika Gakkai Zasshi; 2013 May; 102(5):1105-13. PubMed ID: 23847974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.